Recorded Webinar: Computation in Drug Discovery — An Insider’s View
Webinar: Computation in Drug Discovery — An Insider’s View
Recorded live December 1, 2022
Computational and data-driven drug discovery approaches are promising to revolutionize the biopharmaceutical industry. On a practical level, however, research teams need to overcome a number of challenges to truly harness the power of data and turn it into discoveries.
In this webinar, we've invited two industry veterans, Drs. Josh Horan (Nuvalent) and Michael Kappler (IDEAYA Biosciences), to share their first-hand experience working with data at leading biotech companies. We will go beyond the hype of AI/machine learning and dive into the nuts and bolts of building computational drug discovery capabilities from the ground up.
Eric Gifford, PhD
Customer Success Scientist, CDD
Eric Gifford is a Customer Success Scientist at Collaborative Drug Discovery. Prior to joining CDD, he had a long tenure with multinational pharmaceutical companies Merck and Pfizer where he lead many informatics projects.
Joshua Horan, PhD
VP Medicinal Chemistry, Nuvalent
Joshua Horan is the Vice President of Medicinal Chemistry at Nuvalent Inc, a biotech company creating precisely targeted therapies for patients with cancer. Previously Dr. Horan worked at Proteostasis Therapeutics, working in phenotypic drug discovery. He started his career at Boehringer Ingelheim working on small molecule drug discovery in inflammation and immunology.
Michael Kappler, PhD
Head of Research Infomatics, IDEAYA Biosciences
Michael Kappler joined IDEAYA Biosciences, a synthetic lethality-focused precision medicine oncology company, in 2020 to lead its Research Informatics team. Prior to joining IDEAYA, he worked at Nurix, Roche, Amgen, Daylight, and founded Moonlight Informatics & Computing Knowledge LLC.
CDD VAULT by Collaborative Drug Discovery is a simple and 100% secure data management platform hosted through an intuitive web interface
CDD Vault helps your project team manage, analyze, and present chemical structures, biological assays, and other scientific data.